[On the management of retinal blood circulation disorders due to arteriosclerosis and their sequellae].
D000368:Aged; D001161:Arteriosclerosis / Q000150:complications*; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009216:Myopia / Q000188:drug therapy; D009539:Nicotinic Acids / Q000627:therapeutic use; D008517:Phytotherapy; D010946:Plants, Medicinal / Q000627:therapeutic use; D012171:Retinal Vessels; D012431:Rutin / Q000627:therapeutic use; D013923:Thromboembolism / Q000188:drug therapy*; D014785:Vision, Ocular / Q000187:drug effects
D005343:Fibrinolytic Agents; D009539:Nicotinic Acids; D012431:Rutin; D006493:Heparin
Zur Behandlung arteriosklerotisch bedingter Durchblutungsstörungen der Netzhaut und ihrer Folgeerscheinungen.